NCT01456624View on ClinicalTrials.gov

Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fasting and Fed Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2012

Conditions
Healthy
Interventions
DRUG

Megace

800mg

DRUG

DW-ES(B)

625mg

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT01456624 - Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fasting and Fed Condition | Biotech Hunter | Biotech Hunter